Current status of fertility control methods in India

Journal of Biosciences

Volumn 26, Issue 4 SUPPL., 2001, Pages 391-405

  Sharma, R S ^a   Rajalakshmi, M ^b   Jeyaraj, D Antony ^c  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b National Academy of Medical Sciences   (India)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Epididymis; Estrogen; Luteinizing hormone; Ovary; Progesterone; Sperm; Testis; Testosterone; Uterus

Indexed keywords

ANTIGESTAGEN; ANTISPERMATOGENIC AGENT; CONTRACEPTIVE AGENT; EMBELIA RIBES EXTRACT; ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; HERBACEOUS AGENT; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; PIPER LONGUM EXTRACT; UNCLASSIFIED DRUG;

BIRTH RATE; CONDOM USE; CONTRACEPTIVE USE; FAMILY PLANNING; STERILIZATION;

BIRTH CONTROL; DRUG SAFETY; EMBELIA RIBES; EPIDIDYMIS; FAMILY PLANNING; FEMALE STERILIZATION; HORMONAL CONTRACEPTION; HUMAN; IMMUNOCONTRACEPTION; INDIA; INTRAUTERINE CONTRACEPTIVE DEVICE; MALE STERILIZATION; PATIENT COUNSELING; PIPER LONGUM; PLANT; REVIEW; SPERMATOGENESIS; SPERMATOZOON MIGRATION;

INDIA;

EMBELIA; PIPER LONGUM; RIBES;

EID: 0035678312     PISSN: 02505991     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02704741     Document Type: Review

References (142)

1. Prosprects of riboflavin carrier protein (RCP) as an antifertility vaccine in male and female mammals
2. Effect of oral contraceptive agents on vitamin nutrition status
3. Further studies of an intravasal copper device in rats
4. A testicular protein important for fertility has glutathione S-transferase activity and is localized extracellularly in the seminiferous tubules
5. An update on the use of antigestagens in fertility control
6. Regulation of male fertility
7. Metabolic effects of contraceptive steroids
8. Implications of oral contraceptive use on vitamin nutritional status
9. Low dose injectable contraceptive NEN 20 mg monthly. II metabolic side effects
10. Carbohydrate metabolism of Indian women taking steroid contraceptives
11. An ICMR Task Force Study. Evaluating contraceptive choice through the method-mix approach
12. Long-term contraception by steroid releasing implants
13. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestogen
14. Gonadotropin releasing hormone antagonist plus testosterone: A potential male contraceptive
15. Contraceptive vaginal ring: A rising star on the contraceptive horizon
16. Cancer and Steroid Hormone Study. OCs use and the risk of ovarion cancer
17. Cancer and Steroid Hormone Study. OCs use and the risk of endometrial cancer
18. Plant Contraceptives: Translating folklore into scientific application
19. Traditional methods of fertility regulation
20. Effects of aqueous extract of Carica papaya seeds on the reproductive function of male mice
21. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies
22. Breast cancer and hormonal contraceptives: Further results
23. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IDUs oral pills) - An Indian experience
24. Influence of moderate worm infestation on selected population for trials on contraceptives
25. Hormonal contraception and risk of cardiovascular disease: An international perspective
26. Norplant®: Consensus statement and background review
27. Studies on the contraceptive efficacy of Praneem polyherbal cream
28. Effect of follicular phase administration of mifepristone (RU 486) on blastocyst implantation in the rhesus monkey
29. Anti-nidatory effect of a single early post-ovulatory administration of mifepristone (RU486) in the rhesus monkey
30. Non-invasive reversal of intraluminal vas deferens polymer injection induced azoospermia technology
31. Phase I clinical trial of an injectable contraceptive for the male
32. Phase II clinical trial of a vas deferens injectable contraceptive for the male
33. Localization of epitopes for monoclonal antibodies at the N-terminus of the porcine zona pellucide glycoprotein pZPC
34. Immunochemical characterization and antifertility effect of maturation antigens of spermatozoa
35. Task Force on Hormonal Contraception Phase-II randomized clinical trial with norethisterone enanthate 50 mg alone or in combination with 5 mg or 2.5 mg of either estradiol valerate or cypionate as a monthly injectable contraceptive
36. Phase-II randomized comparative clinical trial of Norplant® (Six capsules), with Norplant®-2 (two covered rods) subdermal implants for long term contraception: Report of a 24-months study
37. Randomized clinical trial with intrauterine device (Levonorgestrel intrauterine device (LNG), CuT 380Ag, CuT 220C and CuT 200B): A 36-monthly study
38. A multicentre phase III comparative study of two hormonal contraceptive preparations NET-OEN (50 μg) + E2 Valerate (5 μg) given every month and NETOEN (200 μg) given every 2 months as intramuscular injection: A report of a 12-months study
39. Randomized Clinical trial with triquilar-ED and low-dose combination pill
40. Task Force on Hormonal Contraception Phase-III clinical trial with Norplant®-2 (two covered rods): Report on five years of use
41. A multicentric clinical trial with RU-486 followed by 9-methylene PGE2 vaginal gel for termination of early pregnancy: A dose-finding study
42. Improved utilization of spacing methods Intrauterine devices (IUDs) and low dose combined oral contraceptive (OCs)-through reorientation training for improving quality of services
43. Task Force on Natural Family Planning, Field Trial of Billing Ovulation method of Natural Family Planning
44. 1, (misoprostol) for termination of early pregnancy within 28 days of missed menstrual period
45. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestogen components
46. Risk of acute myocardial infarction and low-doses combined oral contraceptives
47. Effect of an Ayurvedic preparation on peripheral parameters of the menstrual cycle
48. Short-term effect of oral and norgestrel on the vitamin B6 and B1 status of women
49. Effects of oestrogen containing oral contraceptives on platelet and plasma ascorbic concentrations
50. An ICMR Task Force on IUD and hormonal contraceptives. Clinical evaluation of Intrauterine Devices CuT 200 and CuT 380A - An Experience on 5 years use
51. Centchroman
52. Copper intravas device (IVD) and male contraception
53. Early Pregnancy termination in rats immunized with denatured thiamin carrier protein in pregnant rats by using monoclonal antibodies
54. Strategies for designing an immunocontraceptive vaccine based on zona pellucida synthetic peptides and recombinant antigen
55. Inhibition of sperm maturation in rhesus monkey by cyproterone acetate
56. Effect of cyproterone acetate on structure and function of rhesus monkey reproductive organs
57. Effects of testosterone buciclate on testicular and epididymal sperm functions in bonnet monkeys (Macaca radiata)
58. 9-Net)-LHRH on testicular function and sperm morphology in adult male rhesus monkeys
59. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility
60. New era for injectables
61. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women
62. Third generation oral contraceptives and risk of myocardial infarction: An international case-control study
63. Antifertility investigations on the crude chloroform extract of Carica papaya Linn. seeds in male albino rats
64. Synergism of LH-RH agonist and testosterone in induction of reversible azoospermia in langur monkeys (Presbytis entellus entellus)
65. Human sperm immobilization effect of Carica papaya seed extracts: An in vitro study
66. Repeated vas occlusion and non-invasive reversal with styrene maleic anhydride for male contraception in langur monkeys
67. Intravasal contraception with styrene maleic anhydride and its noninvasive reversal in langur monkeys (Presbytis entellus entellus)
68. Reversible contraception with chloroform extract of Carica papaya Linn. seeds in male rabbits
69. Limitations in developing gossypol acetic acid as a male contraceptive
70. Effects of cyproterone acetate with combination of testosterone enanthate on seminal characteristics and androgenicity and clinical chemistry in langur monkey
71. Reversible sterility by cyproterone acetate plus testosterone enanthate in langur monkey with maintenance of libido
72. Decisions for Norplant programme
73. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and D-norgestrel
74. Progesterone-testosterone trials for male contraception
75. Immunization of male bonnet monkeys (M. radiata) with a recombinant FSH receptor preparation affects testicular function and fertility
76. Long-term contraception with depo-provera: A Clinical evaluation
77. (MCH and Family Planning) India 1998-99 2
78. Changes in binding of lectins to epididymal, ejaculated, and capacitated spermatozoa of the rhesus monkey
79. Solid-phase lectin assay to study surface lectin binding sites on rhesus monkey spermatozoa
80. Anti-implantation activity of luteal phase mifepristone administration is not mimicked by prostaglandin synthesis inhibitor or endometrium analogue in the rhesus monkey
81. Effects of luteal phase administration of mifepristone (RU486) and prostaglandin analogue or inhibitor on endometrium in the rhesus monkey
82. Contraceptive efficacy and safety of centchroman with biweekly-cum weekly schedule
83. Oral contraceptives in the United States: Trends in content and potency
84. Ischaemic stroke and combined oral contraceptives: Results of an international, multicentre, case-control study
85. Effect of oral contraceptive agents on nutrients I minerals
86. Effect of progesterone antagonist, lilopristone (ZK 98.734) on induction of menstruation, inhibition of nidation and termination of pregnancy in bonnet monkeys
87. Effects of progesterone antagonist ZK 98.299 on early pregnancy and foetal outcome in bonnet monkeys
88. Induction of azoospermia by hormonal methods in non-human primates
89. Preclinical evaluation of androgens for the development of male contraceptive
90. Evaluation of the ability of levonorgestrel butanoate alone or in combination with testosterone buciclate to suppress spermatogenesis in the bonnet monkey (Macaca radiata)
91. Pharmacokinetics and pharmacodynamics of a new long-acting androgen ester: Maintenance of physiological androgen levels for 4 months after a single injection
92. Histology of the epididymis in men with obstructive infertility
93. Suppression of testicular and epididymal functions in a non-human primate (bonnet monkey) by combined administration of a gonadotropin-releasing hormone antagonist and testosterone buciclate
94. Effect of dihydrotestosterone on testicular and accessory gland function in male rhesus monkeys
95. Effect of non-aromatizable androgens on testicular and accessory gland function in male rhesus monkey (Macaca mulatta)
96. Reversible antifertility action of testosterone propionate in human males
97. Volatile fraction of neem oil as a spermicide
98. Barrier methods for contraceptive and STD protection
99. Studies with cyproterone acetate for male contraception
100. A randomised double blind study of the effects of two low dose combined oral contraceptives on biochemical aspects. Report from a seven centred study
101. Identification of sperm antigens that regulate fertility
102. Effects of STS-557 and 20 Aet-1 on sperm functions and serum levels of testosterone in bonnet monkey (Macaca radiata)
103. Evaluation of efficacy, safety, and reversibility of cyproterone acetate and testosterone buciclate in bonnet monkey
104. Mechanism of action of NIM-76: A novel vaginal contraceptive from neem oil
105. Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) mice
106. Biodegradable delivery system for a birth control vaccine: Immunogenicity studies in rats and monkeys
107. Sperm maturation in rhesus monkey: Changes in ultrastructure, chromatin condensation, and organization of lipid bilayer
108. Third generation oral contraceptives and risk of vernous thromboembolic disorders: An international case-control study
109. Current Status in development of male contraceptives
110. Development of new long acting contraception for women
111. 7α-methyl-19-nor-testosterone (MENT): The optimal androgen for male contraception
112. Comparative studies on the effects of specific immunoneutralization of endogenous FSH or LH on testicular germ cell transformations in the adult bonnet monkey (Macaca radiata)
113. The HSD-hCG vaccine prevents pregnancy in women: Feasibility study of a reversible safe contraceptive vaccine
114. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable expression of spermatogenesis and fertility
115. Two years experience with the copper T 200 in India
116. Preliminary Clinical trial of flowers of Hibiscus rosa-sinensis as an oral contraceptives
117. Stroke and steroid hormonal contraception
118. Combined oral contraceptives: Risks and benefits
119. Long term effects of maternal low-dose progestogenic contraceptives on their nurslings
120. Low-dose progestogenic contraception and the nursing mother
121. Effects of long-term treatment with testosterone enanthate in rhesus monkeys. I. Pharmacokineties of testosterone, testicular volume and liver metabolism of testosterone
122. Effects of long-term use of testosterone enanthate. II. Effects on lipids, high and low density lipoprotein cholesterol and liver function parameters
123. Effects of long-term administration of testosterone enanthate on glucose metabolism in rhesus monkeys
124. Changes in prostate structure and function by long-term administration of an androgen, testosterone enanthate
125. Testosterone prevents complete suppression of spermatogenesis in the gonadotropin-releasing hormone antagonist-treated non-human primate (Macaca fascicularis)
126. Sustained inhibition of sperm production and inhibin secretion induced by a gonadotropin-releasing hormone antagonist and delayed testosterone substitution in non-human primates (Macaca fascicularis)
127. Oral contraceptives and breast cancer resolution emerges (Editorial)
128. Lower dose pills
129. Estrogens and progestogen
130. Multinational Comparative Clinical trial of long-acting injectable contraceptive: Norethisterone given in two doses regimens and depotmedroxyprogesterone acetate. Final report
131. Contraceptive efficacy of testosterone-induced azoospermia in normal men
132. Invasive squamous cell cervical carcinoma and combined oral contraceptives: Results from a multinational study
133. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives 1996 Results of an international, multicentre, case-control study
134. Cardiovascular disease and steroid hormone contraception 1997 Report of a WHO Scientific group
135. World Bank Special Programme of Research, Development and Research Training in Human Reproduction 1998 Developing new methods of fertility regulation
136. Hormonal contraception and post-menopausal hormonal therapy 1999 IARC monographs on the evaluation of carcinogenic risks to human
137. World Bank Special Programme of Research, Development and Research Training in Human Reproduction 2000 Reproductive health research at WHO: A new beginning